255 related articles for article (PubMed ID: 14616353)
1. Imiquimod in basal cell carcinoma: how does it work?
Dummer R; Urosevic M; Kempf W; Hoek K; Hafner J; Burg G
Br J Dermatol; 2003 Nov; 149 Suppl 66():57-8. PubMed ID: 14616353
[TBL] [Abstract][Full Text] [Related]
2. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle.
Berman B; Sullivan T; De Araujo T; Nadji M
Br J Dermatol; 2003 Nov; 149 Suppl 66():59-61. PubMed ID: 14616354
[TBL] [Abstract][Full Text] [Related]
3. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive imaging, treatment, and microscopic confirmation of clearance of basal cell carcinoma.
Goldgeier M; Fox CA; Zavislan JM; Harris D; Gonzalez S
Dermatol Surg; 2003 Mar; 29(3):205-10. PubMed ID: 12614409
[TBL] [Abstract][Full Text] [Related]
5. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo.
Urosevic M; Maier T; Benninghoff B; Slade H; Burg G; Dummer R
Arch Dermatol; 2003 Oct; 139(10):1325-32. PubMed ID: 14568837
[TBL] [Abstract][Full Text] [Related]
7. The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview.
Stockfleth E; Trefzer U; Garcia-Bartels C; Wegner T; Schmook T; Sterry W
Br J Dermatol; 2003 Nov; 149 Suppl 66():53-6. PubMed ID: 14616352
[TBL] [Abstract][Full Text] [Related]
8. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream.
Cowen E; Mercurio MG; Gaspari AA
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S240-8. PubMed ID: 12271286
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod 5% cream: a new treatment option for basal cell carcinoma.
Salasche S
Int J Dermatol; 2002 May; 41 Suppl 1():16-20. PubMed ID: 12087814
[No Abstract] [Full Text] [Related]
10. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.
Papadavid E; Stratigos AJ; Falagas ME
Expert Opin Pharmacother; 2007 Aug; 8(11):1743-55. PubMed ID: 17685890
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod: in superficial basal cell carcinoma.
Oldfield V; Keating GM; Perry CM
Am J Clin Dermatol; 2005; 6(3):195-200; discussion 201-2. PubMed ID: 15943496
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
[TBL] [Abstract][Full Text] [Related]
14. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient.
Kagy MK; Amonette R
Dermatol Surg; 2000 Jun; 26(6):577-8; discussion 578-9. PubMed ID: 10848940
[TBL] [Abstract][Full Text] [Related]
15. To the editor: incompletely excised basal cell carcinoma treated with 5% imiquimod cream.
Rivera A; Markus J; Pielop JA; Orengo I
Dermatol Surg; 2005 Nov; 31(11 Pt 1):1481-2. PubMed ID: 16416627
[No Abstract] [Full Text] [Related]
16. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
Peris K; Campione E; Micantonio T; Marulli GC; Fargnoli MC; Chimenti S
Dermatol Surg; 2005 Mar; 31(3):318-23. PubMed ID: 15841634
[TBL] [Abstract][Full Text] [Related]
17. Treatment of an extensive superficial basal cell carcinoma of the face with imiquimod 5% cream.
Micali M; Nasca MR; Musumeci ML
Int J Tissue React; 2005; 27(3):111-4. PubMed ID: 16372477
[TBL] [Abstract][Full Text] [Related]
18. [How I treat ... basal cell carcinoma by imiquimod].
Piérard-Franchimont C; Nikkels AF; Paquet P; Quatresooz P; Piérard GE
Rev Med Liege; 2005 Apr; 60(4):207-9. PubMed ID: 15943094
[TBL] [Abstract][Full Text] [Related]
19. A preliminary study of imiquimod treatment in variants of basal cell carcinoma.
McCutcheon B; White K; Kotwall C; Germolic D; Rebolloso Y; Hamann MS; Stiles A
Am Surg; 2005 Aug; 71(8):662-5. PubMed ID: 16217949
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells.
Barnetson RS; Satchell A; Zhuang L; Slade HB; Halliday GM
Clin Exp Dermatol; 2004 Nov; 29(6):639-43. PubMed ID: 15550144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
